These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 29635363)

  • 1. Sprouty2 enhances the tumorigenic potential of glioblastoma cells.
    Park JW; Wollmann G; Urbiola C; Fogli B; Florio T; Geley S; Klimaschewski L
    Neuro Oncol; 2018 Jul; 20(8):1044-1054. PubMed ID: 29635363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sprouty2 Drives Drug Resistance and Proliferation in Glioblastoma.
    Walsh AM; Kapoor GS; Buonato JM; Mathew LK; Bi Y; Davuluri RV; Martinez-Lage M; Simon MC; O'Rourke DM; Lazzara MJ
    Mol Cancer Res; 2015 Aug; 13(8):1227-37. PubMed ID: 25934697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of endothelial programmed cell death 10 activates glioblastoma cells and promotes tumor growth.
    Zhu Y; Zhao K; Prinz A; Keyvani K; Lambertz N; Kreitschmann-Andermahr I; Lei T; Sure U
    Neuro Oncol; 2016 Apr; 18(4):538-48. PubMed ID: 26254477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epithelial membrane protein 1 promotes glioblastoma progression through the PI3K/AKT/mTOR signaling pathway.
    Miao L; Jiang Z; Wang J; Yang N; Qi Q; Zhou W; Feng Z; Li W; Zhang Q; Huang B; Chen A; Zhang D; Zhao P; Li X
    Oncol Rep; 2019 Aug; 42(2):605-614. PubMed ID: 31233190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ZWINT: A potential therapeutic biomarker in patients with glioblastoma correlates with cell proliferation and invasion.
    Yang L; Han N; Zhang X; Zhou Y; Chen R; Zhang M
    Oncol Rep; 2020 Jun; 43(6):1831-1844. PubMed ID: 32323832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glioblastoma Cell Resistance to EGFR and MET Inhibition Can Be Overcome via Blockade of FGFR-SPRY2 Bypass Signaling.
    Day EK; Sosale NG; Xiao A; Zhong Q; Purow B; Lazzara MJ
    Cell Rep; 2020 Mar; 30(10):3383-3396.e7. PubMed ID: 32160544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sprouty2 inhibits amphiregulin-induced down-regulation of E-cadherin and cell invasion in human ovarian cancer cells.
    Cheng JC; Chang HM; Xiong S; So WK; Leung PC
    Oncotarget; 2016 Dec; 7(49):81645-81660. PubMed ID: 27835572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IGFBP2 induces SPRY1 expression via NF-κB signaling pathway in glioblastoma multiforme (GBM).
    Yuan ZS; Cao Y; Li ZY
    Eur Rev Med Pharmacol Sci; 2017 Nov; 21(22):5072-5080. PubMed ID: 29228449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reactive species balance via GTP cyclohydrolase I regulates glioblastoma growth and tumor initiating cell maintenance.
    Tran AN; Walker K; Harrison DG; Chen W; Mobley J; Hocevar L; Hackney JR; Sedaka RS; Pollock JS; Goldberg MS; Hambardzumyan D; Cooper SJ; Gillespie Y; Hjelmeland AB
    Neuro Oncol; 2018 Jul; 20(8):1055-1067. PubMed ID: 29409010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LRIG2 promotes the proliferation and cell cycle progression of glioblastoma cells in vitro and in vivo through enhancing PDGFRβ signaling.
    Xiao Q; Dong M; Cheng F; Mao F; Zong W; Wu K; Wang H; Xie R; Wang B; Lei T; Guo D
    Int J Oncol; 2018 Sep; 53(3):1069-1082. PubMed ID: 30015847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypoxia inducible factors regulate the transcription of the sprouty2 gene and expression of the sprouty2 protein.
    Gao X; Hicks KC; Neumann P; Patel TB
    PLoS One; 2017; 12(2):e0171616. PubMed ID: 28196140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MARCKS regulates growth and radiation sensitivity and is a novel prognostic factor for glioma.
    Jarboe JS; Anderson JC; Duarte CW; Mehta T; Nowsheen S; Hicks PH; Whitley AC; Rohrbach TD; McCubrey RO; Chiu S; Burleson TM; Bonner JA; Gillespie GY; Yang ES; Willey CD
    Clin Cancer Res; 2012 Jun; 18(11):3030-41. PubMed ID: 22619307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of EGFR trafficking and cell signaling by Sprouty2 and MIG6 in lung cancer cells.
    Walsh AM; Lazzara MJ
    J Cell Sci; 2013 Oct; 126(Pt 19):4339-48. PubMed ID: 23868981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sprouty2 regulates proliferation and survival of multiple myeloma by inhibiting activation of the ERK1/2 pathway in vitro and in vivo.
    Yao Y; Luo J; Bian Y; Sun Y; Shi M; Xia D; Niu M; Zhao K; Zeng L; Chen W; Li Z; Xu K
    Exp Hematol; 2016 Jun; 44(6):474-482.e2. PubMed ID: 27016275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sprouty 2: a novel attenuator of B-cell receptor and MAPK-Erk signaling in CLL.
    Shukla A; Rai K; Shukla V; Chaturvedi NK; Bociek RG; Pirruccello SJ; Band H; Lu R; Joshi SS
    Blood; 2016 May; 127(19):2310-21. PubMed ID: 26809508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Constitutive CHK1 Expression Drives a pSTAT3-CIP2A Circuit that Promotes Glioblastoma Cell Survival and Growth.
    Khanna A; Thoms JAI; Stringer BW; Chung SA; Ensbey KS; Jue TR; Jahan Z; Subramanian S; Anande G; Shen H; Unnikrishnan A; McDonald KL; Day BW; Pimanda JE
    Mol Cancer Res; 2020 May; 18(5):709-722. PubMed ID: 32079743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A non-hierarchical organization of tumorigenic NG2 cells in glioblastoma promoted by EGFR.
    Al-Mayhani TF; Heywood RM; Vemireddy V; Lathia JD; Piccirillo SGM; Watts C
    Neuro Oncol; 2019 Jun; 21(6):719-729. PubMed ID: 30590711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RCC2 promotes proliferation and radio-resistance in glioblastoma via activating transcription of DNMT1.
    Yu H; Zhang S; Ibrahim AN; Wang J; Deng Z; Wang M
    Biochem Biophys Res Commun; 2019 Aug; 516(3):999-1006. PubMed ID: 31277942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Ig superfamily protein PTGFRN coordinates survival signaling in glioblastoma multiforme.
    Aguila B; Morris AB; Spina R; Bar E; Schraner J; Vinkler R; Sohn JW; Welford SM
    Cancer Lett; 2019 Oct; 462():33-42. PubMed ID: 31377205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reducing VDAC1 expression induces a non-apoptotic role for pro-apoptotic proteins in cancer cell differentiation.
    Arif T; Krelin Y; Shoshan-Barmatz V
    Biochim Biophys Acta; 2016 Aug; 1857(8):1228-1242. PubMed ID: 27080741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.